Grace Therapeutics, Inc.
Ticker: 1444192
values in millions
| Period | Q3 FY2021 |
|---|---|
| INCOME | |
| Revenue | 0.08 |
| Total Income | 0.08 |
| EXPENSES | |
| Expenditure | 2.05 |
| PROFIT | |
| Net Profit | -3.22 |
| KEY METRICS | |
| OPM % | -100.00% |
| NPM % | -100.00% |
Corporate Events
Board MeetingGRCE
202617Sep
Board Meeting
Annual Meeting of Stockholders to elect five directors, appr…
SEC Filing ↗ Board MeetingGRCE
20265Jun
Board Meeting
Vice President of Clinical Operations Transition — Carrie D’…
SEC Filing ↗